Sotorasib plus panitumumab and 5-fluorouracil in first-line treatment of patients with unresectable KRAS G12C mutated colorectal cancer unfit for a doublet/triplet chemotherapy: ENGIC 01 - PRODIGE 107 - FFCD 2306 - COLOSOTO trial. - Grancher A; Landi M; Ballhausen A; Vidal Tocino R; Alig A; Taravella A; Le Malicot K; Soularue E; Gallois C; Guarssifi M; Pelkowski M; Beltran M; et al. (Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2026)